Claudio Majul

Tirzepatide versus insulin glargine in type 2 diabetes and increased cardiovascular risk (SURPASS-4): a randomised, open-label, parallel-group, multicentre, phase 3 trial

Stefano Del Prato, Steven E. Kahn, Imre Pávó et al. · The Lancet · 2021 · 586 citations

Metabolic Syndrome, Diabetes Management, Cardiovascular Disease +9

Efficacy and safety of aldosterone synthase inhibition with and without empagliflozin for chronic kidney disease: a randomised, controlled, phase 2 trial

Katherine R. Tuttle, Sibylle J. Hauske, María Eugênia Fernandes Canziani et al. · The Lancet · 2023 · 151 citations · Full text

Hypertension, Renal Function, Renal Disease +10

Results of Treatment With Telmisartan‐Amlodipine in Hypertensive Patients

Thomas Littlejohn, Claudio Majul, Rafael Olvera et al. · Journal of Clinical Hypertension · 2009 · 92 citations · Full text

Blood Pressure Monitoring, Peripheral Edema, Hypertension +13

Snoring, witnessed sleep apnoeas and pregnancy‐induced hypertension

Daniel Pérez-Chada, Alejandro J. Videla, Martín O’Flaherty et al. · Acta Obstetricia Et Gynecologica Scandinavica · 2007 · 81 citations · Full text

Original Research: Telmisartan plus Amlodipine in Patients with Moderate or Severe Hypertension: Results from a Subgroup Analysis of a Randomized, Placebo-Controlled, Parallel-Group, 4 × 4 Factorial Study

Thomas Littlejohn, Claudio Majul, Rafael Olvera et al. · Postgraduate Medicine · 2009 · 58 citations